The public issue is a completely fresh issue of up to Rs 290 crore, with no offer-for-sale component, as per the Red Herring ...
Everfront Biotech Holding has filed for an initial public offering with the Securities and Exchange Commission. The biopharmaceutical company, which focuses on new drug discovery and development, didn ...
The DRHP outlines a total offer size of up to 83.75 lakh equity shares, comprising a fresh issue of up to 50 lakh equity ...
GEN uncovers seven biopharma-related trends based on interviews with experts and other industry stakeholders, as well as ...
Demand for Big Data services is increasing. Palantir, a leader in the field, should benefit. Here are the forecasts and price ...
On December 20, 2024, the U.S. Securities and Exchange Commission (the “SEC”) issued a press release highlighting settled enforcement actions ...
NEW YORK (AP) — The following is a list of initial public offerings planned for the coming week. Sources include IPO ETF manager Renaissance Capital, and SEC filings.
Brain cancer drug developer NeOnc Technologies (NTHI) plans to go public via a direct listing, roughly six months after pulling its IPO. Read more here.
Could biotech’s tepid IPO market finally turn around in 2025? A new federal administration and the expected departure of FTC ...
The National Stock Exchange in India achieved a landmark moment by facilitating the highest number of IPOs across Asia, raising approximately Rs 1.67 lakh crore in 2024. This represents the ...
Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that int ...
Ardent Health has acquired 18 facilities from urgent care provider NextCare, following through on its plan to expand its urgent and ambulatory care presence.